Construction of gene-expression predictor model for patient outcome with renal cell carcinoma
肾细胞癌患者预后的基因表达预测模型的构建
基本信息
- 批准号:18591764
- 负责人:
- 金额:$ 2.49万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2006
- 资助国家:日本
- 起止时间:2006 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Renal cell carcinomas (RCCs) are morphologically and genetically heterogeneous tumors and present diverse clinical courses. We used real-time quantitative PCR to examine the VCAMI and ADFP expression levels of more than 400 clear cell renal carcinomas. We evaluated their significances with respect to patient survival rates using the Cox regression model combined with the split-sample method. We demonstrated that high VCAM1 expression is strongly associated with cancerfine survival for patients with clear cell RCC after curative surgical resection. On the other hand, high ADFPexpression was associated with better cancerspecific survival. Next, We developed a scoring system using levels of gene expression to predict outcome for clear cell RCC patients. We selected differentially expressed genes firom the DNA microarray data of 27clear cell RCCs; 16 were metastasis phenotypes and 11 were not We compared the selected gene set with previously published data and identified 33 overlapping gen … More es closely associated with patient outcome. We selected the 12 top-ranked genes and confirmed the level of expression using quantitative reverse transcriptase PCR Multivariate Cox analysis revealed that three genes-要ascular cell adhesion molecule 1 (VCAM1), endothelin receptor type B (EDNRB), and regulator of G-protein signaling 5 (RGS5)-were the most tightly associated with cancerspecific survival and that higher expression of the three genes correlated with better outcome. A formula for an outcome predictor was generated from integration of the measurements of the expression levels of the three genes. Multivariate Cox models combined with a split-sample cress-validation method in a cohort of 386 clear cell RCC patients demonstrated that the derived score for outcome prediction was an independent predictor in cancerspecific survival tests. The accuracy of the prediction of cancer death after nephrectomy was improved by the inclusion of this score in receiver operating characteristic (ROC) analysis from multivariate logistic regression models, suggesting that a scoring system based on the expression levels of these three genes is useful in the prediction of survival far patients with clear cell RCC. Less
肾细胞癌 (RCC) 是形态和遗传异质性肿瘤,具有不同的临床过程,我们使用实时定量 PCR 检查了 400 多种透明细胞肾癌的 VCAMI 和 ADFP 表达水平,并评估了它们对患者的意义。另一方面,我们使用分割样本法的 Cox 回归模型证明,高 VCAM1 表达与治愈性手术切除后合并透明细胞肾细胞癌的患者的癌症良好生存率密切相关。另一方面,高 ADFP 表达与更好的癌症特异性生存相关,我们从 27 个透明细胞 RCC 的 DNA 微阵列数据中选择了差异表达的基因,该系统使用基因表达水平来预测转移。我们将选定的基因集与之前发表的数据进行比较,并确定了 33 个与患者结果密切相关的重叠基因。我们选择了 12 个排名最高的基因,并确认了这些基因。使用定量逆转录酶 PCR 多变量 Cox 分析的表达水平显示,三个基因 - 血管细胞粘附分子 1 (VCAM1)、B 型内皮素受体 (EDNRB) 和 G 蛋白信号传导调节因子 5 (RGS5) - 关联最紧密与癌症特异性生存相关,并且这三个基因的较高表达与更好的结果相关,这是通过将三个基因的表达水平的测量值与分割样本相结合而生成的。在 386 名透明细胞 RCC 患者队列中进行的 cress 验证方法表明,结果预测的衍生评分是癌症特异性生存测试中的独立预测因子。通过在接受者中纳入该评分,提高了肾切除术后癌症死亡预测的准确性。多变量逻辑回归模型的操作特征(ROC)分析表明,基于这三个基因表达水平的评分系统可用于预测透明细胞肾细胞癌患者的生存率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Expression of adipose differentiation-related protein : A predictor of cancer-specific survival in clear cell renal carcinoma.
脂肪分化相关蛋白的表达:透明细胞肾癌中癌症特异性生存的预测因子。
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Yao M; Nakaigawa N; Nagashima Y; et al.
- 通讯作者:et al.
Identification and characterization of the Birt-Hogg-Dube associated renal carcinoma.
Birt-Hogg-Dube 相关肾癌的鉴定和表征。
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Murakami T; Nakaigawa N; Nagashima Y; Yao M; et. al.
- 通讯作者:et. al.
A Novel Machine Learning 13-Gene Signature: Improving Risk Analysis and Survival Prediction for Clear Cell Renal Cell Carcinoma Patients
新型机器学习 13 基因特征:改善透明细胞肾细胞癌患者的风险分析和生存预测
- DOI:10.3390/cancers14092111
- 发表时间:2022-04-24
- 期刊:
- 影响因子:5.2
- 作者:Terrematte, Patrick;Andrade, Dhiego Souto;Justino, Josivan;Stransky, Beatriz;de Araujo, Daniel Sabino A.;Neto, Adriao D. Doria
- 通讯作者:Neto, Adriao D. Doria
Expression of adipose differentiation-related protein: A predictor of cancer-specific survival in clear cell renal carcinoma.
脂肪分化相关蛋白的表达:透明细胞肾癌中癌症特异性生存的预测因子。
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Yao M; Nakaigawa N; Nagashima Y; et al.
- 通讯作者:et al.
Vascular cell adhesion molecule 1 predicts cancer-free survival in clear cell renal carcinoma patients.
血管细胞粘附分子 1 可预测透明细胞肾癌患者的无癌生存。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Shioi K; Nakaigawa N; Nagashima Y; et al.
- 通讯作者:et al.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YAO Masahiro其他文献
YAO Masahiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YAO Masahiro', 18)}}的其他基金
Analyses of tumorigenesis and identifications of novel diagnostic marker and therapeutic target in hereditary and rare kidney cancers
遗传性和罕见肾癌的肿瘤发生分析以及新型诊断标志物和治疗靶点的鉴定
- 批准号:
19K09717 - 财政年份:2019
- 资助金额:
$ 2.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular Genetic analysis and Tumorigenesis of Birt-Hogg-Dube syndrome in Japan
日本 Birt-Hogg-Dube 综合征的分子遗传学分析和肿瘤发生
- 批准号:
15K10600 - 财政年份:2015
- 资助金额:
$ 2.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of gene signatures associated with renal tumor characteristics and its clinical applications
肾肿瘤特征相关基因特征的鉴定及其临床应用
- 批准号:
21592053 - 财政年份:2009
- 资助金额:
$ 2.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of the VHL Tumor Suppressor Gene in Kidney Cancer
肾癌VHL抑癌基因分析
- 批准号:
13671662 - 财政年份:2001
- 资助金额:
$ 2.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Functional Analysis of the von Hippel-Lindau Disease Tumor Suppressor Gene
冯·希佩尔-林道病肿瘤抑制基因的功能分析
- 批准号:
10671488 - 财政年份:1998
- 资助金额:
$ 2.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular Genetic Study of the VHL Tumor Suppressor Gene in Human Renal Cell Carcinoma
人肾细胞癌VHL抑癌基因的分子遗传学研究
- 批准号:
08671829 - 财政年份:1996
- 资助金额:
$ 2.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
谷丙转氨酶GPT2通过组蛋白修饰促进培唑帕尼耐药的肾透明细胞癌血管拟态形成的机制研究
- 批准号:82303233
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MAP2K6/PDHA1/HILPDA介导的脂质清除抑制肾透明细胞癌进展的机制和功能研究
- 批准号:82372843
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SOX18通过TGF-β1-AKT-ERK途径抑制肾透明细胞癌特异性免疫反应的作用及分子机制
- 批准号:82302070
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肾透明细胞癌BAP1突变抑制肥大细胞浸润促进肿瘤微环境相关免疫逃逸的机制研究
- 批准号:82303748
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肾透明细胞癌SR‑B1突变诱导胆固醇代谢失衡激活hedgehog通路的机制与靶向干预研究
- 批准号:82373176
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Elucidating the Consequences of Chromosome 3 Arm Aneuploidies in Squamous Cell Carcinoma
阐明鳞状细胞癌中染色体 3 臂非整倍体的后果
- 批准号:
10736206 - 财政年份:2023
- 资助金额:
$ 2.49万 - 项目类别:
Investigating the Role of KEAP1 Germline and Somatic Mutations in Renal Cell Carcinoma
研究 KEAP1 种系和体细胞突变在肾细胞癌中的作用
- 批准号:
10740481 - 财政年份:2023
- 资助金额:
$ 2.49万 - 项目类别:
Synthetic Lethal Targeting of SETD2 in Renal Cell Carcinoma
SETD2 在肾细胞癌中的合成致死靶向
- 批准号:
10607320 - 财政年份:2023
- 资助金额:
$ 2.49万 - 项目类别:
Systems analysis of mechanisms driving response to immunotherapy in clear cell cancers
透明细胞癌免疫疗法驱动反应机制的系统分析
- 批准号:
10704140 - 财政年份:2022
- 资助金额:
$ 2.49万 - 项目类别:
Project III: Engineering immunogenic cell death in melanoma and renal cell carcinoma.
项目 III:工程化黑色素瘤和肾细胞癌中的免疫原性细胞死亡。
- 批准号:
10525194 - 财政年份:2022
- 资助金额:
$ 2.49万 - 项目类别: